GSK’s Advair, Serevent Add “Black Box” On Rare Asthma-Related Deaths

GlaxoSmithKline has revised labeling for Advair and Serevent to include "black box" warnings on an increased risk of asthma-related deaths in patients taking salmeterol

More from Archive

More from Pink Sheet